PP89 Health Technology Assessment: Access To Innovative Medicines In The USA And Organization For Economic Cooperation And Development
Natalie LaHood · 2025
Read PP89 Health Technology Assessment: Access To Innovative Medicines In The USA And Organization For Economic Cooperation And Development by Natalie LaHood (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768781.txt.
Description
Natalie LaHood wrote a 2025 study on how health technology assessment, or HTA, shapes access to new drugs. In HTA, expert groups weigh the worth of a new drug before public insurance agrees to pay for it. More countries have used HTA over the past ten years, and its growth may change how fast patients get new drugs.
The study tracked new drugs cleared for sale between 2014 and 2023 by drug agencies in Europe, the United States, and Japan. It then checked which public plans paid for each drug and how many patients used it in each country. In the United States, HTA still plays no formal role in payment choices, while its role grew in other rich countries. The study helps readers see how review rules can speed or slow access to new care.
Catalog record
| CREATOR | Natalie LaHood |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |